Delivery Order SPE2DR25D9112-SPE2DR26FDER5
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,493.75 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for FASENRA PEN 30 MG/ML. The award was issued on January 26, 2026, under a firm fixed-price contract structure with an ultimate completion date of January 27, 2026. No set-aside designation was used for this procurement. DMS Pharmaceutical Group Inc., which has been registered in the System for...
- The Defense Logistics Agency awarded a delivery order valued at $24,937.50 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of FASENRA PEN 30 MG/ML. This firm fixed-price delivery order, issued on January 23, 2026, with an ultimate completion date of January 26, 2026, was awarded without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The award...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,962.50 to DMS Pharmaceutical Group Inc. for FASENRA Pen 30 mg/ml on January 29, 2026. This firm fixed-price delivery order, with an ultimate completion date of January 30, 2026, was issued without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,481.25 to DMS Pharmaceutical Group Inc. for FASENRA Pen 30 mg/ml on January 9, 2026, with completion targeted for January 12, 2026. This firm fixed-price delivery order was issued without a set-aside designation, allowing DMS Pharmaceutical Group to compete on an unrestricted basis. DMS Pharmaceutical Group is a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, that specializes in...
- The Defense Logistics Agency (DLA) issued a delivery order valued at $2,493.75 to DMS Pharmaceutical Group Inc. for FASENRA Pen 30 mg/mL, a biologic pharmaceutical product. Awarded on January 8, 2026, this firm fixed-price delivery order is issued without set-aside designation and reflects DMS Pharmaceutical Group's competitive capability in unrestricted federal procurement. The place of performance is Park Ridge, Illinois, with an ultimate completion date of January 9, 2026. This delivery order...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $9,975.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of FASENRA PEN 30 MG/ML. The award, issued on January 29, 2026, with an ultimate completion date of January 30, 2026, carries no set-aside designation, indicating the contractor competed on an unrestricted basis. This delivery order is issued under DMS...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $2,493.75 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for FASENRA Pen 30 mg/mL. The delivery order, issued on January 29, 2026, with an ultimate completion date of January 30, 2026, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This delivery order is issued...
- The Defense Logistics Agency awarded a $29,925 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for FASENRA PEN 30 MG/ML. The delivery order, issued on January 30, 2026, with an ultimate completion date of February 2, 2026, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This award falls under DMS Pharmaceutical...
- The Defense Logistics Agency issued a delivery order valued at $14,962.50 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of FASENRA PEN 30 MG/ML. This firm fixed-price delivery order, awarded on January 5, 2026, with an ultimate completion date of January 6, 2026, was issued without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The award...
- The Defense Logistics Agency awarded a $9,975 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for FASENRA PEN 30 MG/ML. This delivery order, issued on January 9, 2026, with an ultimate completion date of January 12, 2026, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The award falls under DMS Pharmaceutical...
- SPE2DR25D9112Indefinite Delivery Contract
- SPE2DR25D9112-SPE2DR26FDER5Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,975 on February 3, 2026, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of FASENRA Pen 30 mg/ml. This firm fixed-price delivery order carries an ultimate completion date of February 4, 2026, and was issued without a set-aside designation, reflecting the contractor's competitive capability in unrestricted federal procurement. The award is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion federal acquisition strategy established to support recurring pharmaceutical supply needs of Department of Defense military healthcare facilities worldwide. DMS Pharmaceutical Group has been registered in the System for Award Management since July 2001 and serves as a critical supplier within the federal pharmaceutical supply chain, demonstrating substantial federal contracting activity through numerous delivery orders issued by the DLA's Medical Supply Chain division. The company's comprehensive product portfolio encompasses branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical consumables. Under the PPV-G GEN V prime vendor contract awarded on November 13, 2025, with a $500 million ceiling value and completion date of December 31, 2036, DMS Pharmaceutical Group is positioned as one of multiple regional prime vendor contractors authorized to deliver diverse and specialized pharmaceutical requirements supporting Department of Defense healthcare operations globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.0k | 2/2/26 |